V. Loustaud‐Ratti - Concepedia

Author

V. Loustaud‐Ratti

Also Known As

Albert Tran, Anne Wampach, Cristina Julia Lisbona, Hervé Hagège, Loustaud-Ratti, Veronique, Loustaud-Ratti, Véronique, Nicolas Limal, P.-H Bernard, V Loustaud-Ratti, V. LOUSTAUD-RATTI

347

Publications

Citations

H-Index

103

Concepts

All Affiliations

Inserm Université de Limoges Hôpital Dupuytren Centre Hospitalier Universitaire de Limoges Sorbonne Université

About

V. Loustaud‐Ratti is an author at Inserm specializing in medicine, viral hepatitis, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	41	4.2K
2	Public Health	3	3	642
3	Engineering	1	1	26
4	Health Sciences	1	2	876
5	Natural Sciences	1	1	90

V. Loustaud‐Ratti

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study Fabrice Carrat, Hélène Fontaine, Céline Dorival, The Lancet HepatologyHepatitis CViral HepatitisClinical EpidemiologyChronic Hepatitis C	2019	612
Extrahepatic Manifestations Associated with Hepatitis C Virus Infection: A Prospective Multicenter Study of 321 Patients P. Cacoub, Christophe Renou, Éric Rosenthal, Medicine	2000	561
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890 Christophe Hézode, Hélène Fontaine, Céline Dorival, Journal of Hepatology HepatologyAnrs Co20-cupicViral HepatitisTriple TherapyHepatitis	2013	431
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS) Marc Bourlière, Jean-Pierre Bronowicki, Victor de Lédinghen, The Lancet Infectious Diseases HepatologyViral HepatitisAntiviral Drug DevelopmentHcv Genotype 1Hepatitis	2015	280
Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis Christophe Hézode, Hélène Fontaine, Céline Dorival, Gastroenterology HepatologyHepatitis CViral HepatitisHcv Genotype 1Hepatitis	2014	259
Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection Gregory T. Everson, Karen Sims, M. Rodríguez‐Torres, Gastroenterology	2013	198
Sjögren Syndrome Associated With Hepatitis C Virus Manuel Ramos‐Casals, V. Loustaud‐Ratti, Salvatore De Vita, Medicine VasculitisImmunologyPathologyViral HepatitisSjögren Syndrome Associated	2005	172
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection Luca Arcaini, Caroline Besson, Marco Frigeni, Blood	2016	171
Routine vs Extensive Malignancy Search for Adult Dermatomyositis and Polymyositis A. Sparsa, É. Liozon, François R. Herrmann, Archives of Dermatology	2002	148

Page 1